A Rare Cell State Underpins Diverse Mechanisms of Adaptive Resistance to CAR T-Cell Therapy in B-Cell Acute Lymphoblastic Leukemia
James A. Kuzich(The University of Melbourne), Mark A. Dawson(The University of Melbourne), Andrew A. Guirguis(Peter MacCallum Cancer Centre), Ashley P. Ng(The Royal Melbourne Hospital), Phillip K. Darcy(Peter MacCallum Cancer Centre), Paul A. Beavis(Peter MacCallum Cancer Centre), Dane Vassiliadis(The University of Melbourne), Laure Talarmain(The University of Melbourne), Jack D. Chan(The University of Melbourne)
Cited by 1
Related Papers
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
|Nature|2011|1.5k
An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer
|Cancer Cell|2019|630
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
|New England Journal of Medicine|2018|429